Search results
IP Risks from AI’s Role In Drug Discovery | Law.com
Law.com· 19 hours agoDrug discovery involving artificial intelligence (AI) tools has quickly occupied significant territory in the pharmaceutical industry. One study found...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 6 days agoImmuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, advises that Stephen Anastasiou has resigned from his position as Non-Executive ...
Earnings call: Vir Biotechnology reports Q1 2024 financials, pipeline progress
Investing.com· 6 days agoThe company announced the introduction of two new independent directors and the exit of Chief...
Time-course RNAseq data of murine AB1 mesothelioma and Renca renal cancer following immune...
Nature· 6 days agoHere, we present whole tumor RNA sequencing data in the context of treatment with ICB in murine models of AB1 mesothelioma and Renca renal cell cancer. We sequenced 144 bulk RNAseq samples from ...
Adaptive Biotechnologies Expects Growth From FDA Panel MRD Vote, Cuts Staff by 7 Percent in Q1
GenomeWeb News· 1 day agoThe Seattle-based immune sequencing firm also shed light on its strategic review that will separate its MRD and immune medicine businesses, disclosing that it reduced its headcount by almost ...
CDC says bird flu viruses "pose pandemic potential," cites major knowledge gaps
WINK TV Southwest Florida· 5 days agoBird flu continues to appear to pose a “low risk to the general public” for now, the Centers for...
FDA Finalizes Rule to Phase Out Enforcement Discretion of Laboratory-Developed Tests | JD Supra
JD Supra· 2 days agoOn April 29, the U.S. Food and Drug Administration (FDA) released a final rule that will gradually phase out FDA’s long-standing policy of enforcement discretion for laboratory-developed tests ...
Elrexfio and dosage: Strengths, form, when to use, and more
Medical News Today· 3 days agoElrexfio (elranatamab-bcmm) is a brand-name drug that’s prescribed for specific cases of multiple...
Gilead cuts jobs, trims drugs amid deeper biopharma pullback - San Francisco Business Times
The Business Journals· 6 days agoGilead Sciences Inc. will cut 58 jobs at its Foster City campus after writing off $2.4 billion for a cancer drug that was the cornerstone of a $21 billion acquisition and ...
CDC says bird flu viruses "pose pandemic potential," cites major knowledge gaps
CBS News· 6 days agoBird flu continues to appear to pose a "low risk to the general public" for now, the Centers for...